ALDAMA PHARMACEUTICALS
LIVE

Serial Number

99266049

Owner

Aldama Pharmaceuticals, Inc.

Attorney

Eric T. Fingerhut

Filing Date

Jul 3, 2025

Add to watchlist:

No watchlists yet
View on USPTO

ALDAMA PHARMACEUTICALS Trademark

Serial Number: 99266049

ALDAMA PHARMACEUTICALS is a trademark filed by Aldama Pharmaceuticals, Inc. on July 3, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Aldama Pharmaceuticals, Inc. (17 trademarks)

3307 NW 74th Avenue
Miami, FL 33122

Entity Type: 03

Trademark Details

Filing Date

July 3, 2025

Registration Date

Not Registered

Published for Opposition

May 26, 2026

Goods & Services

Dietary supplements; Pharmaceutical preparations for the treatment of a wide variety of diseases, conditions and disorders, namely, infectious diseases, cardiovascular diseases, respiratory diseases, gastrointestinal diseases, metabolic and endocrine disorders, neurological diseases and disorders, psychiatric and mental health disorders, namely, anxiety disorder, depression disorder, substance use disorder, post-traumatic stress disorder, and bipolar disorder, autoimmune and inflammatory diseases, musculoskeletal disorders, dermatological diseases, oncological diseases, hematological disorders, renal and urological diseases, hepatic diseases, ophthalmic diseases, otic diseases, allergic diseases, immunological disorders, pain and pain related conditions, namely, chronic low back pain, osteoarthritis, migraine and chronic headache disorders, fibromyalgia, and neuropathic pain, sleep disorders, reproductive and sexual health disorders, hormonal disorders, nutritional deficiencies, genetic disorders, namely, down syndrome, Klinefelter syndrome, cystic fibrosis, sickle cell disease and Marfan syndrome, and chronic and acute medical conditions, namely, hypertension, type 2 diabetes, asthma, acute myocardial infarction, and pneumonia

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 21, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 26, 2026 NPUB
PUBLISHED FOR OPPOSITION
May 26, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 20, 2026 NONP
AMENDMENT/PETITION AFTER APPROVAL FOR PUB ENTERED
May 4, 2026 AMPB
ASSIGNED TO LIE
May 4, 2026 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Apr 28, 2026 PARI
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 24, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 24, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 24, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 24, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 24, 2026 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 24, 2026 GNFN
FINAL REFUSAL E-MAILED
Apr 24, 2026 GNFR
FINAL REFUSAL WRITTEN
Apr 24, 2026 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 12, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 12, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 12, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 12, 2026 GNRN
NON-FINAL ACTION E-MAILED
Feb 12, 2026 GNRT
NON-FINAL ACTION WRITTEN
Feb 12, 2026 CNRT
EXAMINER'S AMENDMENT ENTERED
Jan 21, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 21, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 21, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 21, 2026 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 8, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 8, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 8, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 6, 2025 GNRN
NON-FINAL ACTION E-MAILED
Dec 6, 2025 GNRT
NON-FINAL ACTION WRITTEN
Dec 6, 2025 CNRT
ASSIGNED TO EXAMINER
Nov 20, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Nov 10, 2025 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 10, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Jul 3, 2025 MAFR
NEW APPLICATION ENTERED
Jul 3, 2025 NWAP